SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors deramiocel FDA decision for Duchenne muscular dystrophy, with a Nov. 22 target action date, dominates discussion; traders are weighing the amended upper-limb data and recent launch-related job postings as possible positive signs against the risk of another rejection. The FDAs rare-disease focus and INOVIOs approval are also cited as encouraging read-throughs, but approval expectations remain speculative and sentiment is divided.

OFFICIAL TRUMP (TRUMP) is a cryptocurrency and operates on the Solana platform. OFFICIAL TRUMP has a current supply of 999,998,809.831273 with 281,866,746.118905 in circulation. The last known price of OFFICIAL TRUMP is 1.73532194 USD and is up 9.97 over the last 24 hours. It is currently trading on 744 active market(s) with $259,407,006.57 traded over the last 24 hours. More information can be found at https://gettrumpmemes.com/.

Trump For President

A short-term bounce in the Trump-themed memecoin is drawing FOMO and pump/squeeze calls, but the conversation is predominantly bearish: traders describe it as a speculative pump-and-dump and warn of further losses, while some continue to promote accumulation or another rally.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

AAOI is drawing attention after a sharp, volatile selloff alongside AI and optical-infrastructure peers, with traders pointing to broader concerns about AI spending, valuations and possible further dilution rather than a clear company-specific trigger. Bulls are buying the dip on data-center transceiver demand and upcoming earnings, while bears remain concerned about financing, customer concentration and execution risks.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

Attention centers on claims that POET optical engines were featured in Foxconns photonics ecosystem, which bullish traders view as validation of the existing collaboration and its AI-data-center opportunity; skeptics note that a demo or ecosystem mention is not proof of production orders. Traders are also weighing the reported Marvell-Lumentum deal and upcoming company updates against POETs steep decline and lack of clear commercial execution.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisks shares plunged despite strong results and a raised outlook, as traders focused on Kioxias cautious forecast and fears that NAND pricing growth and the AI-driven memory cycle may be cooling, alongside broader weakness in chip stocks. The community is split between seeing the selloff as an overreaction to solid fundamentals and viewing it as a warning that peak memory pricing and growth could be near.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovins steep selloff ahead of earnings is driving attention, with traders linking the pressure to analyst downgrades, weakness across tech and ad-related stocks, and concerns about advertising demand. Bulls argue the companys growth and cash flow make the shares undervalued, while bears worry that results or guidance could disappoint and extend the decline.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

Attention centers on ABCL635, AbCelleras investigational non-hormonal treatment for menopausal hot flashes, following positive Phase 2 results and discussion of additional safety data and longer-term durability. Traders are optimistic about the drugs potential, while others caution that the early results still need to be confirmed in further studies; recent analyst coverage has added to the interest.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

A sharp gold selloff and break of support dominate discussion, with traders pointing to repriced Fed-rate expectations and possible liquidation pressure as gold falls alongside risk assets. The community is split between calling it a failed safe haven with more downside ahead and viewing the decline as a buying opportunity or temporary washout.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus is drawing attention ahead of its Q3 results, with traders debating whether growth in oncology testing and data licensing can support the stock after its sharp, volatile run. Bulls point to expanded pharma partnerships and short-squeeze potential, while bears cite insider selling, valuation concerns, and a history of post-earnings pullbacks.

Avalanche (AVAX) is a cryptocurrency launched in 2020. Avalanche has a current supply of 470,737,946.01960015 with 444,069,146.01960015 in circulation. The last known price of Avalanche is 8.66516494 USD and is up 1.34 over the last 24 hours. It is currently trading on 1133 active market(s) with $335,296,203.46 traded over the last 24 hours. More information can be found at https://avax.network/.

Avalanche

A sharp AVAX rebound has traders focused on institutional adoption and real-world asset tokenization, especially reports of a Goldman Sachs treasury fund using an Avalanche-based network. Bulls see the activity as validation of the tokenization theme, while skeptics argue the rally may be speculative and point to AVAXs history of giving back gains.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tesla-SpaceX Merger Needs No Premium, Investor Says — But Floats $500 To Sway Angry Holders Missing Bigger Payoff 

Equity

Larry Goldberg warned that angry Tesla shareholders could reject a merger he believes would benefit both investor groups.

Cathie Wood’s ARK Invest Adds Archer, Joby Shares For Second Straight Day — Retail Bulls Say 'Only Up From Here' 

ARK Invest bought 884,681 Joby shares and 524,515 Archer shares, investing $6.6 million. 


Cathie Wood’s ARK Invest Loads Up On Joby, Archer Aviation As Aerospace Bets Expand 

ARK Invest bought 1.1 million Archer shares and 434,012 Joby shares, investing $6.5 million. 

Cathie Wood Says Tesla, SpaceX Could Drive Up To 9% GDP Growth: ARK Sees Merger As Win For Both Shareholder Bases 

ARK models a 3.8-fold boost to Tesla investor returns and a 7.2-fold boost to SpaceX investors’ incremental returns.

Fed Is Using The ‘Wrong Policy’ To Tackle Inflation, Rising Bond Yields, Says Mohamed El-Erian: Calls For Fiscal Restraint 

In an interview with CNBC, the economist said the Fed was likely to leave interest rates unchanged this week, but anticipates hawkish messaging amid persistent inflation concerns.


Cathie Wood's ARK Invest Adds These Nuclear Names For A Second Straight Day Even As Their Shares Have Plummeted More Than 60% In 2026

On Wednesday, ARK Investment Management reported purchasing Oklo and X-Energy stocks for a combined value of $3.42 million across multiple exchange-traded funds.

RKLB Stock’s Slide Hits Day 7: Cathie Wood’s ARK Buys The Dip As Rocket Lab Touts Mars Record Amid Neutron Delay 

Rocket Lab highlighted its hardware’s role in Perseverance’s record-setting 28.1-mile journey on Mars.

Cathie Wood-Led Ark Invest Sells AMD, SPCX, GOOG Stocks — But Loads Up On CMPS, NTLA, CRSP And Other Healthcare Firms

The trades put some of Ark's better-known holdings on the sell side, including AMD, Alphabet, and SpaceX, while its genomics-focused ARK Genomic Revolution ETF continued to add to biotech companies.

JOBY Stock Drops To Near Two-Year Lows After Barclays Downgrade On Manufacturing Capacity Doubts 

Sector peer Archer Aviation, meanwhile, gained a bullish outlook from Barclays. 

RKLB Rises Overnight: Cathie Wood’s ARK Puts Neutron ‘Close To The Falcon 9’ — Firms ‘In Dire Need’ Of Launches 

SpaceX’s Starlink and upcoming StarMind deployments could create an opening for Rocket Lab if Neutron delivers.

ARK ETF Trust - ARK Autonomous Technology & Robotics ETF

Bullish Sentiment

<ul class="summary-bullets"><li>He said Tesla shareholders do not need a premium to benefit from a SpaceX merger.</li><li>Goldberg argued that a lower premium could offer greater long-term value through the SpaceX shares investors would receive.</li><li>He also said combining assets and cash flows could help finance a computing buildout costing $500 billion to $1 trillion.</li></ul>Tesla shareholders do not need a premium to benefit from a SpaceX merger, LumaSenti managing partner Larry Goldberg said, while floating $500 a share as a figure that could persuade reluctant investors to back a deal.<a href="https://stocktwits.com/symbol/TSLA">TSLA stock</a> rose 4% to close at $407.46 on Tuesday, while&nbsp;<a href="https://stocktwits.com/symbol/SPCX">SPCX</a> gained 1% to $148.58.<h2 class="st-heading-2">Goldberg: A $500 Compromise Could Get Merger Deal Done</h2>“I don’t think a premium is warranted. But if that’s what it takes for these, you know, very angry, angry shareholders, fine, pay it,” Goldberg said in an&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.youtube.com/watch?v=I4s0m6kID8k">interview</a> with Tesla influencer Herbert Ong.When asked what could win investors over, he said: “I think the number that would get you guys off the dime is $500.” Goldberg’s priority is completing a merger rather than holding out for a particular price. “Again, it doesn’t make any difference to me. I just want to get it done,” he said.Goldberg said investors should consider the value of the shares they would receive alongside the price assigned to their Tesla holdings. “The lower the premium, the higher the value of the SpaceX stock that you get in exchange,” he said.“So you guys are so focused on the price of your Tesla shares. You’re not thinking about the SpaceX shares you’re going to get instead and its future, because that’s going to be your future.” His argument rests partly on timing. He sees SpaceX’s opportunity as nearer-term, while Tesla’s longer-term potential carries greater uncertainty.“And therefore, even though Tesla may be worth more over time than SpaceX, the SpaceX opportunity is right today. So why not combine the value today with the value tomorrow?” he said. Goldberg also said that combining the companies’ assets and cash flows could help finance a computing buildout he estimated could require between $500 billion and $1 trillion, depending on its scale.<h2 class="st-heading-2">Goldberg Pushes Back Against Tesla Holders</h2>Goldberg said his position had attracted bitter pushback from Tesla investors focused on their shares’ current value and expectations of much higher future prices. “I mean, it’s in everybody’s interest to merge these companies, you know, and give equal value. However, they can’t see it, and they’re going to vote against it as a result,” he said.Goldberg believes retail investors are overlooking the deal’s long-term value. He also rejected claims that his stance reflected a larger SpaceX stake. “Everybody says I own more SpaceX than I own Tesla. Well, they don’t know, and they’re wrong,” he said, without detailing his holdings. “But from my perspective, the sooner this thing happens, the better.”<h2 class="st-heading-2">The Price Of Winning TSLA, SPCX Shareholder Approval</h2>Other investors see a case for paying up. Altimeter Capital founder Brad Gerstner suggested a&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/altimeter-s-gerstner-puts-420-550-range-on-tesla-in-potential-space-x-merger/cZxMJBxRBvs">$420 to $550 range</a> for Tesla and added that a premium above 30% could help its special committee defend against potential litigation.Separately, ARK’s latest modeling projected benefits for both shareholder groups from a no-premium share swap. Splitting the additional upside equally implied a 24% premium to Tesla’s Oct.23 closing price.Tesla’s quarterly filing confirms that a special committee is exploring a deeper relationship with SpaceX, potentially including a business combination. Musk has said both companies’ independent committees have not agreed on terms and that he is excluded from their discussions because of his conflict of interest. He also said Tesla would need approval from 50% of all shares.<h2 class="st-heading-2">How Do Retail Traders Feel About TSLA And SPCX?</h2>On Stocktwits, retail sentiment for both TSLA and SPCX was ‘bearish’, with message volume ‘high’ for TSLA and ‘normal’ for SPCX.&nbsp;One user&nbsp;<a href="https://stocktwits.com/MarkLucas0/message/667481125">said</a>, “$SPCX&nbsp; is dropping after the valuation of Tesla on merging with SPCX. Tesla will benefit, and SPCX will dilute.”<stembedurl>https://stocktwits.com/MarkLucas0/message/667481125</stembedurl>Another user&nbsp;<a href="https://stocktwits.com/StrongArmor/message/667492291">said</a>, “$TSLA 500 low side imo to 600 if merger happens. Just my thoughts. 420 break would be key as 460 likely next stop where resistance is.”<stembedurl>https://stocktwits.com/StrongArmor/message/667492291</stembedurl>While TSLA stock has declined 9% year-to-date, SPCX has fallen 8% over the same period.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/sls-stock-blackrock-spotlight-3-aml-data-bulls-spot-gps-approval-forecast/cZU9PrPRB6X">SLS Stock Gets A BlackRock Spotlight Ahead Of Phase 3 AML Data — Bulls Spot 2027 European GPS Approval Forecast&nbsp;</a>

 Elon Musk speaks onstage during the "Exploring the New Frontiers of Innovation: Mark Read in Conversation with Elon Musk" session at the Lumiere Theatre.

Tesla-SpaceX Merger Needs No Premium, Investor Says — But Floats $500 To Sway Angry Holders Missing Bigger Payoff

ARK Innovation ETF

ARK Autonomous Technology & Robotics ETF

Leverage Shares 2x Long SPCX Daily ETF

Tradr 2X Long SpaceX Daily ETF

Tidal Trust II - Defiance Daily Target 2X Short SpaceX ETF

SpaceX

Direxion Daily TSLA Bull 2X Shares

Tradr 2X Short TSLA Daily ETF

T-REX 2X Long Tesla Daily Target ETF

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

ARKQ ARK Autonomous Technology & Robotics ETF

Fundamentals

Latest ARKQ News